Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor α soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3α and increases that of collagen in an in vitro model of rheumatoid synoviocyte activation

Annals of the Rheumatic Diseases

Volumn 61, Issue 8, 2002, Pages 730-733

  Chevrel, G ^a   Garnero, P ^a   Miossec, P ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 6; MACROPHAGE INHIBITORY PROTEIN 3ALPHA; MACROPHAGE MIGRATION INHIBITION FACTOR; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG; BETA CHEMOKINE; BIOLOGICAL MARKER; CCL20 PROTEIN, HUMAN; CCR6 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; IL17R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL MIGRATION; CLINICAL ARTICLE; DENDRITIC CELL; DISEASE MARKER; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; METABOLISM; MIDDLE AGED; MONOCYTE; SYNOVIUM;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHEMOKINES, CC; FEMALE; HUMAN; INTERLEUKIN-6; MACROPHAGE INFLAMMATORY PROTEINS; MALE; MIDDLE AGE; MONOCYTES; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SYNOVIAL MEMBRANE; HUMANS; MIDDLE AGED; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-17;

EID: 0035997489     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.8.730     Document Type: Article

References (15)

1. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
2. The combination of tumor necrosis factor α blockade with interleukin-1 and interleukin-17 blockade is more effective For controlling synovial inflammation and bone resorption in an ex vivo model
3. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites
4. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
5. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
6. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
7. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
8. Strategies of anti-cytokine monoclonal antibody development: Immunoassay of IL-10 and IL-5 in clinical samples
9. Enhancing effect of IL-1, IL-17, and TNF-α on macrophage inflammatory protein-3α production in rheumatoid arthritis: Regulation by soluble receptors and Th2 cytokines
10. Human interleukin-17. A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
11. Recombinant human interleukin-1 receptor type 1 in the treatment of patients with active rheumatoid arthritis
12. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines
13. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis
14. Interleukin-17: A new bone acting cytokine in vitro
15. Functional differentiation of dendritic cells in rheumatoid arthritis: Role of CD86 in the synovium